UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 7, 2026
Accession Number:
0001193125-26-332796
Submission Type:
POS AM
CIK:
0001563577
Company Name:
Galera Therapeutics, Inc.
File Number:
333-251061